Fetomaternal alloimmunization with antenatal glomerulopathies

Annals of the New York Academy of Sciences

Volumn 1110, Issue , 2007, Pages 559-566

  Debiec, Hanna ^a,b   Ronco, Pierre ^a  

^a INSERM   (France)

^b HÔPITAL TENON   (France)

Author keywords

Alloepitopes; Fetomaternal alloimmunization; Membranous nephropathy; Neutral endopeptidase

Indexed keywords

ANTIBODY; ANTIGEN; AUTOANTIGEN; EPITOPE; IMMUNOGLOBULIN; MEMBRANE METALLOENDOPEPTIDASE; RITUXIMAB; SYNTHETIC PEPTIDE;

ALLOIMMUNIZATION; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIGEN BINDING; BLOOD PLACENTA BARRIER; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; DIAGNOSTIC TEST; DRUG MEGADOSE; GLOMERULOPATHY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; NONHUMAN; PLACENTA; PODOCYTE; PRENATAL PERIOD; RISK ASSESSMENT;

EID: 35748952506     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1423.060     Document Type: Conference Paper

References (26)

1. DEBIEC, H. et al. 2002. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N. Engl. J. Med. 346: 2053-2060.
2. TURNER, A.J., R.E. ISAAC & D. COATES. 2001. The neprilysin (NEP) family of zinc metalloendopeptidases: genomics and function. Bioessays 23: 261-269.
3. DEBIEC, H. et al. 2004. Role of truncating mutations in MME gene in feto-maternal allo-immunization and neonatal glomerulopathies. Lancet 364: 1252-1259.
4. HÖRL, W.H. & D. KERJASCHKI. 2000. Membranous glomerulonephritis (MGN). J. Nephrol. 13: 291-316.
5. CUNNINGHAM, P.N. & R.J. QUIGG. 2005. Contrasting roles of complement activation and its regulation in membranous nephropathy. J. Am. Soc. Nephrol. 16: 1214-1222.
6. PLATT, J.L., W.L. TUCKER & A.F. MICHAEL. 1983. Stages of renal ontogenesis identified by monoclonal antibodies reactive with lymphohematopoietic differentiation antigens. J. Exp. Med. 157: 155-172.
7. RONCO, P. & H. DEBIEC H. 2005. Molecular pathomechanisms of membranous nephropathy: from Heymann nephritis to alloimmunization. J. Am. Soc. Nephrol. 16: 1205-1213.
8. KESTILA, M. et al. 1998. Positionally cloned gene for a novel glomerular protein-nephrin is mutated in congenital nephrotic syndrome. Mol. Cell. 1: 575-582.
9. BOUTE, N. et al. 2000. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat. Genet. 24: 349-354.
10. KAPLAN, J.M. et al. 2000. Mutations in ACTN4, encoding a-actinin-4, cause familial focal segmental glomerulosclerosis. Nat. Genet. 24: 251-256.
11. NORTIER, J. et al. 2006. Neonatal disease in neutral endopeptidase alloimmunization : lessons for immunological monitoring. Pediatric Nephrol. 21: 1399-1405.
12. SIMISTER, N.E. 2003. Placental transport of immunoglobulin G. Vaccine 21: 3365-3369.
13. CLARK, M.R. 1997. IgG effector mechanisms. Chem. Immunol. 65: 88-110.
14. TURNER, A.J. et al. 2000. The neprilysin family in health and disease. Adv. Exp. Med. Biol. 477: 229-240.
15. IKEDA, K. et al. 1999. Molecular identification and characterization of novel membrane-bound metalloprotease, the soluble secreted form of which hydrolyzes a variety of vasoactive peptides. J. Biol. Chem. 274: 32469-32477.
16. BONVOULOIR, N. et al. 2001. Molecular cloning, tissue distribution, and chromosomal localization of MMEL2, a gene coding for a novel human member of the neutral endopeptidase-24.11 family. DNA Cell Biol. 20: 493-498.
17. REINEKE, U. et al. 1999. A synthetic mimic of a discontinuous binding site on interleukin-10. Nat. Biotechnol. 17: 271-275.
18. COLLINET, P. et al. 2002. Successful treatment of extremely severe fetal anemia due to alloimmunization. Obstet. Gynecol. 100: 1102-1105.
19. WHITINGTON, P.F. & J.U. HIBBARD. 2004. High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis. Lancet 364: 1690-1698.
20. RUGGENETI, P. et al. 2003. Rituximab in idiopathic membranous nephropathy: a one-year prospective study. J. Am. Soc. Nephrol. 14: 1851-1857.
21. WU, H.Y. & H.L. WEINER. 2003. Oral tolerance. Immunol. Res. 28: 265-284.
22. MAYER, L. & L. SHAO. 2004. Therapeutic potential of oral tolerance. Nat. Rev. Immunol. 4: 407-419.
23. REYNOLDS, J. et al. 2005. Nasal administration of recombinant rat alpha3(IV)NC1 prevents the development of experimental autoimmune glomerulonephritis in the WKY rat. J. Am. Soc. Nephrol. 16: 1350-1359.
24. HALL, A.M. et al. 2005. Immune responses and tolerance to the RhD blood group protein in HLA-transgenic mice. Blood 105: 2175-2179.
25. URBANIAK, S.J. & M.A. GREIS. 2000. RhD haemolytic disease of the fetus and the newborn. Blood Rev. 14: 44-61.
26. ROZMAN, P. 2002. Platelet antigens. The role of human platelet alloantigens (HPA) in blood transfusion and transplantation. Transpl. Immunol. 10: 165-181.